Oncologist Urge FDA to Allow Cancer Patients Access to Silicone Implants, But Continue Study
In Brief: Healy to Name Jay Moskowitz Deputy Direct, Promote Mahoney To Deputy Budge Director
NCI To File Record No. Of INDS In ’92, Expand Phase 1 Trials
Advisors Ok New RFP For Natural Product Large-Scale Production
National Coalition Dinner Honors Cancer Program Founders, Advocates, And Cancer Survivors
DES Exposure Studies Below Payline; NCI Considers Contracts
ICCCR Issues RFP For Cancer Risk Scale
Trending Stories
- Richard Pazdur left FDA to avoid being part of “the destruction of the American medical system”
- In first NCAB director’s report, Anthony Letai focuses on centralized grant review, budget outlook
- Pazdur leaves FDA after 25-year career that shaped the agency’s oncology regulations
BIO calls for the end of “constant turmoil,” urges the administration to “right the ship” - Pediatric cancer five-year survival rate has increased dramatically, AACR says in inaugural Pediatric Cancer Progress Report
- Anthony Letai pledges to ensure stability for extramural and intramural cancer science
- Vinay Prasad to CBER employees: “It is not wise for FDA to further pollute the scientific literature with papers we cannot defend”









